Didier Landais
Vorstandsvorsitzender bei 4P-Pharma
Profil
Didier Landais is the Chief Executive Officer at 4P-Pharma since 2023.
Prior to this, he worked as a Project Leader at Rhone Poulenc AG, Inc., Vice President & Head-Development at Biotecnol-Serviços e Desenvolvimento SA, and Chief Operating & Business Officer at LabGenius Ltd.
Dr. Landais holds an MBA from ESSEC Business School and undergraduate, graduate, and doctorate degrees from the University of Strasbourg.
Aktive Positionen von Didier Landais
| Unternehmen | Position | Beginn |
|---|---|---|
| 4P-Pharma | Vorstandsvorsitzender | 01.09.2023 |
Ehemalige bekannte Positionen von Didier Landais
| Unternehmen | Position | Ende |
|---|---|---|
| Rhone Poulenc AG, Inc. | Corporate Officer/Principal | - |
Labgenius Ltd.
 Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom. | Geschäftsführer | - |
Biotecnol-Serviços e Desenvolvimento SA
 Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Corporate Officer/Principal | - |
Ausbildung von Didier Landais
| ESSEC Business School | Masters Business Admin |
| University of Strasbourg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
| Rhone Poulenc AG, Inc. | Process Industries |
Biotecnol-Serviços e Desenvolvimento SA
Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Commercial Services |
Labgenius Ltd.
Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
| 4P-Pharma | Commercial Services |
